Related Experiment Video
Updated: Mar 16, 2026

05:25
Author Spotlight: Expanding the Scope of Multiplex Immunoassays for Lyme Borreliosis Diagnostics and Pathogen Research
Published on: July 14, 2023
2.1K
Multiplex method for initial complex testing of antibodies to blood transmitted diseases agents
Alexander G Poltavchenko1, Oleg V Nechitaylo1, Pavel V Filatov1
1Vector State Research Center of Virology and Biotechnology, 630559, Koltsovo, Novosibirsk Region, Russia.
Journal of Virological Methods
|August 8, 2016
Summary
A new multiplex diagnostic kit allows for rapid, low-cost screening of blood products for six major infectious diseases. This innovation simplifies initial complex testing for blood-transmitted agents, improving efficiency and accessibility.
Area of Science:
- Medical Diagnostics
- Biotechnology
- Infectious Diseases
Background:
- Current screening for blood-transmitted diseases uses expensive, time-consuming monospecific tests.
- High-risk populations and blood donors require efficient initial screening methods.
Purpose of the Study:
- To develop a cost-effective multiplex test for simultaneous detection of multiple blood-borne pathogens.
- To create a rapid initial screening tool for blood products.
Main Methods:
- Development of a multiplex dot-immunoassay kit utilizing protein arrays (immune chips).
- The assay employs colloidal gold conjugates and silver development for antibody detection.
- Simultaneous detection of antibodies against HIV, Hepatitis B, Hepatitis C, Cytomegalovirus, T. pallidum, and T. gondii.
Main Results:
- The multiplex kit provides results within 70 minutes at room temperature.
- No specialized personnel are required for conducting the assay.
- Dot-assay results showed strong correlation with commercial Enzyme-Linked Immunosorbent Assay (ELISA) kits.
- Multiplex analysis is faster, cheaper, and suitable for non-laboratory settings compared to ELISA.
Conclusions:
- The developed multiplex dot-immunoassay kit significantly simplifies initial complex testing for blood-transmitted agents.
- This approach offers a rapid, cost-effective, and accessible screening solution.
- The kit has the potential to improve the safety of blood products through efficient initial screening.

